Qing Bu
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 12, 2024
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China.
Journal: Lancet (London, England)
Published: September 14, 2024
Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial.
Journal: Signal transduction and targeted therapy
Published: September 13, 2024
Expanding individualized therapeutic options via genoproteomics.
Journal: Cancer letters
Published: January 04, 2023
High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma.
Journal: Current molecular medicine
Published: January 04, 2023
Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.
Journal: World journal of surgical oncology
Published: October 31, 2021
Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients.
Journal: Journal of oncology
Published: October 11, 2020
Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics analysis.
Journal: Translational cancer research
Published: November 14, 2018
The benefits of psychosocial interventions for cancer patients undergoing radiotherapy.
Journal: Health and quality of life outcomes
Published: February 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026